Liquid biopsy panel for the detection of variants in non-small cell lung cancer from cfDNA
The UltraSEEK Lung Panel enables study of disease progression and resistance in non-small cell lung cancer.
- Detect over 70 clinically relevant variants across BRAF, EGFR, ERBB2, KRAS and PIK3CA
- Identify variants at as low as 0.1% variant allele frequency
- Use as little as 10 ng of cfDNA
- 1 hour of hands-on time and 8 hours of total time
Panel Resources